Sign In
Buy SHC
$15.27
+0.250 (+1.66%)
At Close: Jun 03, 2026
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
07:20pm, Tuesday, 19'th May 2026
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Sotera Health Announces Secondary Offering of Common Stock
04:33pm, Monday, 11'th May 2026
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its
Why Broyhill May Be Buying More Sotera Health Shares
03:34pm, Wednesday, 06'th May 2026
Sotera Health offers sterilization and lab testing for healthcare and life sciences clients, supporting global regulatory compliance.
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
12:11pm, Tuesday, 05'th May 2026
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Tuesday, 05'th May 2026
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics comp
Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates
09:26am, Tuesday, 05'th May 2026
Sotera Health Company (SHC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.14 per share a year ago.
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
07:03am, Tuesday, 05'th May 2026
Q1 2026 net revenues increased 10.0%, or 6.5% on a co nstant currenc y basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or
Sotera Health Announces Leadership Transition
07:00am, Tuesday, 05'th May 2026
Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Dir
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates
09:25am, Wednesday, 29'th Apr 2026
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.07 per share a year ago.
Sotera Health Company $SHC Shares Acquired by Cwm LLC
04:09am, Monday, 27'th Apr 2026
Cwm LLC grew its position in shares of Sotera Health Company (NASDAQ: SHC) by 1,235.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Com
Sotera Health Announces First-Quarter 2026 Earnings Release Date
07:46am, Tuesday, 21'st Apr 2026
CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services f
All You Need to Know About Sotera Health (SHC) Rating Upgrade to Buy
01:01pm, Tuesday, 07'th Apr 2026
Sotera Health (SHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Capricorn Fund Managers Ltd Purchases New Shares in Sotera Health Company $SHC
04:43am, Monday, 06'th Apr 2026
Capricorn Fund Managers Ltd purchased a new position in Sotera Health Company (NASDAQ: SHC) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fir
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts
04:43am, Friday, 03'rd Apr 2026
Sotera Health Company (NASDAQ: SHC - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven brokerages that are covering the stock, MarketBeat.com reports. Three equities r
Sotera Health (SHC) Soars 8.2%: Is Further Upside Left in the Stock?
09:16am, Wednesday, 01'st Apr 2026
Sotera Health (SHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term
